期刊文献+

胃肠道恶性肿瘤过继性细胞免疫治疗进展 被引量:1

Progress in adoptive cellular immunotherapy for malignant tumor in gastrointestinal tract
下载PDF
导出
摘要 近年来过继性细胞免疫治疗发展迅速,除了已知对免疫原性较强的肿瘤如黑色素瘤和肾癌等治疗效果良好外,目前已被应用于治疗胃肠道恶性肿瘤并取得了初步成效,有望成为治疗胃肠道恶性肿瘤的有效方法。笔者就胃肠道恶性肿瘤过继性细胞免疫治疗进展作一综述。
出处 《军医进修学院学报》 CAS 2009年第2期232-233,共2页 Academic Journal of Pla Postgraduate Medical School
基金 国家高技术研究发展计划(2006AA02Z4B9)~~
  • 相关文献

参考文献2

二级参考文献18

  • 1Liu Y, Saxena A, Zheng C, et al. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors. J Gene Med, 2004, 6:857-868.
  • 2Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy.Trends Mol Med,2001, 12: 542-547.
  • 3Terando A, Mule JJ. Enhancing dendritic cell-based vaccines by gene modification.Blood Cells Mol Dis, 2003, 31:80-83.
  • 4Meng H, Lu C, Mabuchi H, et al. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett. 2004, 216:147-155.
  • 5Kawasaki H, Altieri DC, Lu CD. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res, 1998, 22:5071-5074.
  • 6Tu SP, Jiang XH, Lin MC, et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res, 2003 , 22:7724-7732.
  • 7Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res, 1998, 9:1808-1812.
  • 8Ito T, Shiraki K, Sugimoto K. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology, 2000, 5:1080-1085.
  • 9Alicia T,James JM.Enhancing dendritic cell-based vaccines by gene modification.Blood Cells Mol Dis,2003,31:80-83.
  • 10Dirk N,Francesco MM,Monica CP.Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays.Cytokine,2004,25:31-35.

共引文献5

同被引文献10

  • 1Zhang YJ, Li M, Meng M, et al. The effect of ulinastatin on the small intestine injury and mast cell degranulation in a rat model of sepsis induced by CLP [ J ]. Exp Toxicol Pathol, 2009, 61 ( 5 ) : 481-490.
  • 2Yang QP, Liu XG, Liu M, et al. Ulinastatin-mediated proteetion against zymosan-indueed multiple organ dysfunction in rats [ J ] . Biologieals, 2010, 38 ( 5 ) : 552-556.
  • 3Nishiyama T, Yokoyarna T, Yamashita K. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery [ J ] . J anesth, 2006, 20 ( 3 ) : 179-182.
  • 4Ni Choileain N, Redmond HP. Cell response to surgery [ J ] . Arch Surg, 2006, 141 ( 11 ) : 1132-1140.
  • 5Page GG. Surgery-indueed and postoperative pain management [ J ] . AACN Clin Issues, 2005, 16 ( 3 ) : 302-309.
  • 6Tsujino T, Kawabe T, Omata Masao. Antiproteases in preventing post-ERCP acute panereatitis [ J ] . JOP, 2007, 8 (4 Suppl ) : 509-517.
  • 7Umeadi C, Kandeel F, Al-Abdullah IH. Ulinastatin is a novel protease inhibitor and neutral protease activator [ J ] . Transplant Proc, 2008, 40 ( 2 ) : 387-389.
  • 8Ma T, Kang CHSH, Shao HW, etal. Protective effects of ulinastatin on proliferation and eytokine release of splenocytes from rats with severe acute pancreatitis [ J ] . Eur Surg Res, 2006, 38 (5) : 445-450.
  • 9Szczesny T, Stotwihski R, Szezesny G. Changes in humoral and cellular immunity in patients operated on due to esophageal Cancer [ J ] . Pol Merkur Lekarski, 2005, 18 ( 106 ) : 478-482.
  • 10陈云强,孙天胜.严重创伤的免疫学研究进展[J].军医进修学院学报,2011,32(7):771-774. 被引量:6

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部